Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Vaccines, Blood & Biologics

Vaccines, Blood & Biologics

                        Infectious Disease Tests


                        Fecal Microbiota Products
          Allergenics
          Blood & Blood Products
          Blood Donor Screening
          Cellular & Gene Therapy Products
          Development & Approval Process (CBER)
          Guidance, Compliance & Regulatory Information (Biologics)
          International Activities
          News & Events (Biologics)
          Resources for You (Biologics)
          Safety & Availability (Biologics)
          Science & Research (Biologics)
          Tissue & Tissue Products
          Vaccines
          Xenotransplantation Home
          Vaccines, Blood & Biologics
          Regenerative Medicine Fellowship under the Service Fellowship Program for CBERVaccines, Blood & Biologics Regenerative Medicine Fellowship under the Service Fellowship Program for CBER
  
  	
    Share
    Post
    Linkedin

    Email
    Print**Now Accepting Applications** 1

Image of ladies looking a computer screen while working together on a project. The image of man and women in the background talking
Regenerative medicine (RM) is an interdisciplinary field, which aims to repair diseased or damaged tissues using biological or cell-based technologies.  This rapidly growing area of biomedical research encompasses cell biology, tissue engineering, drug delivery, and advanced manufacturing, among others.  Regulatory science research at FDA helps to maintain and expand knowledge at the Agency to support development and regulatory review of cutting-edge RM products and associated technologies.

The Office of Therapeutic Products (OTP) within FDA’s Center for Biologics Evaluation and Research (CBER) regulates biological products and certain medical devices related to these products. FDA’s Center for Devices and Radiological Health (CDRH) regulates most medical devices. The Centers facilitate product innovation by advancing regulatory science and assuring consumer confidence in regulated products marketed in the U.S. As many RM products combine biologic and device technology, OTP and CDRH collaborate to support development and regulatory review of such products.

**On this page******

Program Goals

Fellowship structure & Curriculum

Qualifications & Stipend

Application Instructions

**Program Goals**

The Multi-Center Regenerative Medicine Fellowship aims to enhance FDA’s ability to regulate RM products and support the development of highly trained scientists and engineers with unique multi-center experience. Since many RM products involve a combination of biologics and device technology, RM fellows will work across both CBER/OTP and CDRH to facilitate cross-agency collaboration and conduct regulatory science projects related to the regulation of RM products. In connection with a Preceptor(s), each fellow will develop a non-laboratory based regulatory science project to address critical regulatory science priorities and enhance the science that supports regulatory decision-making at FDA, particularly in CBER/OTP and CDRH. Projects are intended to enhance the clinical development of RM products and increase collaboration among CBER, CDRH, and the regulated community.

**Fellowship structure & Curriculum**

Multi-Center Regenerative Medicine Fellowship appointments are 2-3 years. During their appointment, fellows will complete rotations in both CBER/OTP and CDRH, where they will gain “hands-on” experience in the scientific and regulatory premarket review of devices, cell therapy, gene therapy, and tissue-engineered products. Fellows will concurrently develop and finalize a regulatory science project focused on a specific aspect of RM products under the guidance of Preceptors.

The curriculum will include CBER- and CDRH-focused training to provide an in-depth understanding of the science behind regulatory review, as well as encompassing FDA activities across product jurisdictions (e.g., drugs, devices, biologics, and combination products). Coursework will also cover FDA law and policy (including biologics and medical device) and public policy. Fellows will also attend relevant external meetings to increase their scientific and/or regulatory knowledge base.

**Qualifications & Stipend**

This opportunity is open to U.S. citizens and permanent residents (Green Card holders), who are early-career candidates within 5 years of obtaining a Ph.D. or equivalent doctoral degree (e.g., M.D., Sc.D.), awarded by a U.S. science program or a foreign science program certified by national or regional accrediting institutions in the U.S. as meeting all the appropriate requirements leading to a doctorate.  Candidates without a doctoral degree may be considered on a case-by-case basis. See the project descriptions  for additional, project-specific eligibility criteria. CBER/OTP will sponsor 1-3 new RM fellows each year. Stipend will be commensurate with experience.

**Application Instructions**

Interested applicants should provide: 1)  a CV, 2) a copy of doctoral degree and transcripts 3) two to three letters of professional reference from non-government references, and 4) a 1500-word statement of interest to cberservicefellowship@fda.hhs.gov.

**Links**

Framework for the Regulation of Regenerative Medicine productshttps://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/framework-regulation-regenerative-medicine-products
	Regenerative Medicine Advanced Therapy Designationhttps://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/regenerative-medicine-advanced-therapy-designation
	Cellular & Gene Therapy Productshttps://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products


1under the Service Fellowship for CBER

                                                                                  Content current as of:
      06/14/2023
              
              
Regulated Product(s)
		 BiologicsVaccines, Blood & Biologics

          
                        Infectious Disease Tests


                        Fecal Microbiota Products
          Allergenics
          Blood & Blood Products
          Blood Donor Screening
          Cellular & Gene Therapy Products
          Development & Approval Process (CBER)
          Guidance, Compliance & Regulatory Information (Biologics)
          International Activities
          News & Events (Biologics)
          Resources for You (Biologics)
          Safety & Availability (Biologics)
          Science & Research (Biologics)
          Tissue & Tissue Products
          Vaccines
          Xenotransplantation
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop